Health information to help you understand symptoms. It isn't a diagnosis.
Check symptoms

Research deep dives

How leukemia is diagnosed

Last reviewed November 16, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.

Most leukemia is found on a blood count taken for something else, or for symptoms that seemed vague: tiredness, bruising, infections that kept coming back.

From there the question is not only whether it is leukemia but exactly which one, because the subtype and its genetics determine the treatment, the urgency and the outlook. That is why the testing is extensive and why some results take a week or more.

Related pages: Leukemia (blood cancer)

The bottom line

What we know
  • A bone marrow biopsy is required to confirm and classify leukemia.
  • Flow cytometry distinguishes myeloid from lymphoid leukemia within hours.
  • Genetic testing of the leukemia cells changes treatment decisions in most subtypes.
  • Acute promyelocytic leukemia is treated as an emergency before confirmation is complete.
What is still open
  • How much the newest sequencing panels change outcomes, as opposed to classification.
  • The best way to handle the waiting period for patients, which is consistently reported as among the worst parts.

The story, step by step

  1. 1. The blood count ()
  2. 2. Marrow ()
  3. 3. Classifying ()
  4. 4. The rest ()
What the evidence labels mean
GuidelineAn official recommendation from an expert group after weighing all the evidence.
Review of many studiesCombines the results of many studies (a systematic review or meta-analysis).
Randomized trialPeople were randomly given a treatment or a comparison, the best way to test cause and effect.
Large observational studyFollows many people over time. Shows strong links, but not always cause and effect.
Small or early studyA small study, case series, or first results. Needs to be confirmed.
Lab or animal studyDone in cells or animals. May not apply to people.
Part 1 of 4

What first raises the question

Review of many studies

What happens

The test that usually finds it.

What the research shows

  • A complete blood count may show a very high or very low white cell count, low red cells, low platelets, or any combination.
  • The decisive finding is usually blasts: immature cells that should not be circulating. A laboratory noticing blasts on a blood film is what turns a routine count into an urgent referral.
  • A normal white cell count does not rule leukemia out. Some people present with low counts across the board.
  • In chronic lymphocytic leukemia the count often shows a high lymphocyte number in someone who feels entirely well, and the diagnosis can be made on blood tests alone with flow cytometry.
  • Being called back urgently after a blood test is frightening and is usually about getting ahead of a count, not about the worst having already been confirmed.

Why it matters

Speed at this stage reflects that acute leukemia can deteriorate quickly, not that the news is necessarily worse.

What's still uncertain

  • How often early leukemia is missed on a count that looks borderline, which is hard to measure.

Read more

Next: Marrow

Part 2 of 4

The bone marrow biopsy

Review of many studies

What happens

The test that confirms it, and what it is actually like.

What the research shows

  • Two samples are usually taken from the back of the hip bone: an aspirate, which is liquid marrow, and a trephine core, a small cylinder of bone.
  • Local anaesthetic numbs the skin and the bone surface. The aspirate causes a brief, strong pulling sensation that most people describe as the worst few seconds; it lasts moments.
  • Sedation or stronger pain relief is available at many centres and is worth asking about before the day rather than during.
  • The whole procedure takes about 20 to 30 minutes, and the site is sore for a day or two.
  • A diagnosis of acute leukemia is generally made when blasts make up 20 percent or more of marrow cells, with exceptions for certain defining genetic abnormalities.
  • Marrow biopsies are repeated during treatment to assess response, which people find easier once they know what to expect.

Why it matters

Nearly everyone dreads this test more than the experience justifies, and nearly everyone says so afterwards.

What's still uncertain

  • Whether routine sedation improves the experience enough to justify the resources, which centres answer differently.

Read more

Next: Classifying

Part 3 of 4

Flow cytometry and genetics

Review of many studies

What happens

Turning leukemia into a specific diagnosis.

What the research shows

  • Flow cytometry reads the proteins on the surface of the leukemia cells and sorts myeloid from lymphoid, and B-cell from T-cell. It is fast, often back within a day.
  • Cytogenetics examines the chromosomes of the leukemia cells for translocations, deletions and extra copies. A full karyotype takes days because the cells have to be grown first.
  • FISH testing looks for specific abnormalities more quickly, and PCR detects particular fusion genes such as BCR-ABL1, the Philadelphia chromosome.
  • Next-generation sequencing panels test dozens of genes at once. Mutations such as FLT3, NPM1, IDH1 and IDH2 in AML both predict outcome and open specific targeted drugs.
  • These results are the reason treatment may be adjusted a week in. The initial plan often starts before the full genetic picture is back.
  • Acute promyelocytic leukemia is the exception to all waiting: if it is suspected on the blood film, treatment starts immediately, because the bleeding risk in the first days is the main cause of death and is preventable.

Why it matters

This is the step that turned leukemia from four diseases into dozens, and it is why asking for the full name of your diagnosis is worth doing.

What's still uncertain

  • Which of the many mutations now detectable should change treatment, which is being worked out panel by panel.

Read more

Next: The rest

Part 4 of 4

Other tests, and the waiting

Review of many studies

What happens

What else is done, and how to handle the gap.

What the research shows

  • A lumbar puncture is done in acute lymphoblastic leukemia and some other subtypes, because leukemia cells can hide in the spinal fluid; treatment is often given into the fluid at the same time.
  • Imaging checks for enlarged lymph nodes, spleen or liver, and for infection.
  • Heart function is assessed before anthracycline chemotherapy, kidney and liver function before dosing, and infection screening before transplant.
  • Tissue typing for transplant can be started early, including testing siblings, because finding a donor takes time.
  • Ask for a copy of your pathology report. It contains the subtype, the genetics and the risk category, and it is the document every future conversation refers back to.
  • A second opinion at a specialist centre is reasonable and is normal practice in leukemia, particularly for rarer subtypes. For acute leukemia it has to happen in parallel with starting treatment rather than instead of it.
  • The waiting for results is widely described as the hardest part. Asking the team which results are pending, and when each is expected, makes it finite.

Why it matters

Not every result arrives at once, and a plan that changes after a week is usually genetics arriving rather than something going wrong.

What's still uncertain

  • How much second opinions change management in practice, which varies by subtype and centre.

Read more

More plain-language reading

See something wrong or unclear on this page? Suggest a correction. OwieClear is for education only and isn't medical advice.